{"id":"https://openalex.org/W2056425879","doi":"https://doi.org/10.1111/j.1365-2036.1995.tb00438.x","title":"Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease","display_name":"Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease","publication_year":1995,"publication_date":"1995-12-01","ids":{"openalex":"https://openalex.org/W2056425879","doi":"https://doi.org/10.1111/j.1365-2036.1995.tb00438.x","mag":"2056425879","pmid":"https://pubmed.ncbi.nlm.nih.gov/8824656"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2036.1995.tb00438.x","doi":"https://doi.org/10.1111/j.1365-2036.1995.tb00438.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.1995.tb00438.x","pdf_url":null,"source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111364196","display_name":"A. B. R. Thomson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"A. B. R. THOMSON","raw_affiliation_strings":["University of Alberta, Edmonton, Canada","University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Canada","institution_ids":["https://openalex.org/I154425047"]},{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. P. WRIGHT","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J. P. WRIGHT","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000597533","display_name":"M H Vatn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M. VATN","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112394247","display_name":"Robert James Bailey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R. J. BAILEY","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014016506","display_name":"Dan Rachmilewitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. RACHMILEWITZ","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109167689","display_name":"Michael Adler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M. ADLER","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014067828","display_name":"Karen Wilson-Lynch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"K. A. WILSON\u2010LYNCH","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of The International Mesasal Maintenance Study Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"on behalf of The International Mesasal Maintenance Study Group","raw_affiliation_strings":["University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111364196"],"corresponding_institution_ids":["https://openalex.org/I154425047"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":0.7958,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.74756645,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"9","issue":"6","first_page":"673","last_page":"683"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-aminosalicylic-acid","display_name":"5-aminosalicylic acid","score":0.9810000061988831},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9940000176429749},{"id":"https://openalex.org/keywords/remission-maintenance","display_name":"remission maintenance","score":0.9649999737739563},{"id":"https://openalex.org/keywords/crohn-s-disease-activity-index","display_name":"CDAI","score":0.7749999761581421},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7649999856948853},{"id":"https://openalex.org/keywords/crohn-s-colitis","display_name":"Crohn's colitis","score":0.875},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.5130000114440918},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5249999761581421},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5680000185966492},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9435042142868042},{"id":"https://openalex.org/C2779174533","wikidata":"https://www.wikidata.org/wiki/Q412479","display_name":"Mesalazine","level":4,"score":0.8946367502212524},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8003700971603394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7464892864227295},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.6824451684951782},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5942986011505127},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5616083741188049},{"id":"https://openalex.org/C2780941987","wikidata":"https://www.wikidata.org/wiki/Q3796380","display_name":"Ileitis","level":4,"score":0.5469697713851929},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4971189796924591},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.41722720861434937},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41123050451278687},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.38915538787841797},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.37040239572525024},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22471338510513306},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000636","descriptor_name":"Aminosalicylic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000636","descriptor_name":"Aminosalicylic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007079","descriptor_name":"Ileitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013019","descriptor_name":"South Africa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019804","descriptor_name":"Mesalamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2036.1995.tb00438.x","doi":"https://doi.org/10.1111/j.1365-2036.1995.tb00438.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.1995.tb00438.x","pdf_url":null,"source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:8824656","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8824656","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary pharmacology & therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1519313131","https://openalex.org/W1534782991","https://openalex.org/W1570692162","https://openalex.org/W1653242715","https://openalex.org/W1761355724","https://openalex.org/W1999329203","https://openalex.org/W2024513902","https://openalex.org/W2047547287","https://openalex.org/W2048683851","https://openalex.org/W2051019076","https://openalex.org/W2053331429","https://openalex.org/W2057483013","https://openalex.org/W2072188410","https://openalex.org/W2075506798","https://openalex.org/W2087143897","https://openalex.org/W2087407585","https://openalex.org/W2092265847","https://openalex.org/W2098638622","https://openalex.org/W2231635155","https://openalex.org/W2252830500","https://openalex.org/W2303179499","https://openalex.org/W2327815242","https://openalex.org/W2617114566","https://openalex.org/W4231822359","https://openalex.org/W4245057533","https://openalex.org/W4254900502","https://openalex.org/W4302611215"],"related_works":["https://openalex.org/W4300492581","https://openalex.org/W4245057533","https://openalex.org/W2039485883","https://openalex.org/W2087143897","https://openalex.org/W2324655205","https://openalex.org/W4206903017","https://openalex.org/W2002027061","https://openalex.org/W2055241086","https://openalex.org/W1606112346","https://openalex.org/W2978265545"],"abstract_inverted_index":{"UNLABELLED:":[0],"INVESTIGATORS:":[1],"This":[2,208,273],"multicentre":[3],"study":[4,79,196,394],"was":[5,119,297,395],"conducted":[6],"by":[7],"29":[8],"principal":[9],"investigators":[10],"in":[11,29,33,38,54,171,182,188,213,219,258,264,278,284,326,352,361,390,409,413,446],"11":[12],"countries.":[13],"AIMS:":[14],"To":[15],"compare":[16],"the":[17,34,78,116,135,141,148,152,183,189,195,214,220,225,229,259,265,271,279,285,290,298,315,339,343,346,353,357,367,383,396,402,410,414,420,427,448,454],"safety":[18],"and":[19,61,107,168,186,217,245,262,282,303,345,453],"efficacy":[20,295],"of":[21,36,68,77,115,140,178,254,366,377,382,398,404,419,429,436],"oral":[22],"mesalazine":[23],"(Mesasal/Claversal,":[24],"5-ASA)":[25],"1.5":[26,87,450],"g":[27,88,451],"b.d.":[28,89,452],"comparison":[30],"with":[31,41,128,157,234,320,328,336],"placebo":[32,93,190,221,266,286,347,415,455],"maintenance":[35],"remission":[37],"286":[39],"patients":[40,142,156,180,211,233,256,276,319,408],"Crohn's":[42,56,158,235,321,378,421,437],"disease.":[43,117,379],"MATERIALS":[44],"AND":[45],"METHODS:":[46],"Patients":[47,81],"had":[48,62,65,423],"to":[49,63,84,198,239,338,443],"score":[50,124],"less":[51],"than":[52,126],"150":[53],"their":[55],"Disease":[57],"Activity":[58],"Index":[59],"(CDAI),":[60],"have":[64],"one":[66],"period":[67],"clinical":[69],"activity":[70],"(CDAI":[71],">":[72],"150)":[73],"within":[74],"18":[75],"months":[76,102,445],"start.":[80],"were":[82,99,162,165,192,237,242,268,307,312,334,356,386,439],"randomized":[83,238],"receive":[85],"5-ASA":[86,184,215,260,280,344,449],"daily":[90],"or":[91,109,145,160,204,323,325,372,388,401,412],"matching":[92],"for":[94,101,205,441],"12":[95,444],"months.":[96],"Study":[97],"visits":[98],"scheduled":[100],"1,":[103],"3,":[104],"6,":[105],"9":[106],"12,":[108],"when":[110],"symptoms":[111,376],"suggested":[112],"a":[113,122,131],"relapse":[114,340,434],"Relapse":[118],"defined":[120],"as":[121,370],"CDAI":[123],"greater":[125],"150,":[127],"at":[129],"least":[130],"60-point":[132],"increase":[133],"from":[134,194,270],"baseline":[136],"index":[137],"score.":[138],"None":[139],"used":[143],"glucocorticoids":[144],"immunosuppressants":[146],"during":[147],"trial.":[149,227,292],"RESULTS:":[150],"In":[151,228,318,392],"first":[153],"group,":[154,231],"207":[155],"colitis":[159,322],"ileocolitis":[161],"randomized:":[163],"there":[164],"101":[166,210],"females":[167,244],"106":[169,179],"males,":[170,247],"age":[172,248],"range":[173,249],"18-71":[174],"years.":[175,251],"A":[176,252,300],"total":[177,253],"(51":[181,212],"group":[185,216,261,281],"55":[187],"group)":[191,222,267,287],"withdrawn":[193,269],"due":[197],"adverse":[199,399,430],"events,":[200],"insufficient":[201],"therapeutic":[202],"effect,":[203],"other":[206],"reasons.":[207],"left":[209,274],"50":[218],"who":[223,288],"completed":[224,289],"12-month":[226,291],"second":[230],"79":[232],"ileitis":[236],"treatment.":[240],"There":[241],"53":[243],"26":[246],"18-66":[250],"41":[255],"(19":[257],"22":[263],"study.":[272],"38":[275],"(17":[277],"21":[283],"The":[293,380,417,433],"primary":[294],"variable":[296],"CDAI.":[299],"protocol-eligible":[301],"analysis":[302,306],"an":[304],"intent-to-treat":[305],"performed.":[308],"No":[309],"statistical":[310],"differences":[311,333],"noted":[313,335],"between":[314,342,407],"two":[316],"analyses.":[317],"ileocolitis,":[324],"those":[327],"ileitis,":[329],"no":[330,424],"statistically":[331],"significant":[332],"respect":[337],"rates":[341,435],"treatment":[348,363,411,456],"groups.":[349,364,416,457],"Adverse":[350],"events":[351,368,384,400],"gastrointestinal":[354],"system":[355],"most":[358],"frequently":[359],"reported":[360,385],"both":[362,447],"Many":[365],"such":[369],"diarrhoea":[371],"abdominal":[373],"pain":[374],"are":[375],"majority":[381],"mild":[387],"moderate":[389],"severity.":[391],"neither":[393],"prevalence":[397],"proportion":[403],"drop-outs":[405],"different":[406],"site":[418],"disease":[422,438],"effect":[425],"on":[426],"frequency":[428],"events.":[431],"CONCLUSION:":[432],"similar":[440],"up":[442]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}